Bandera C - Search Results

1

Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital.

Schwartz JR, Bandera C, Bradley A, Brard L, Legare R, Granai CO, Dizon DS. Schwartz JR, et al. Among authors: bandera c. Gynecol Oncol. 2007 Apr;105(1):81-3. doi: 10.1016/j.ygyno.2006.10.047. Epub 2006 Dec 8. Gynecol Oncol. 2007. PMID: 17157366

2

Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.

Kuroki L, Stuckey A, Hirway P, Raker CA, Bandera CA, DiSilvestro PA, Granai CO, Legare RD, Sakr BJ, Dizon DS. Kuroki L, et al. Among authors: bandera ca. Gynecol Oncol. 2010 Mar;116(3):295-300. doi: 10.1016/j.ygyno.2009.12.005. Epub 2009 Dec 29. Gynecol Oncol. 2010. PMID: 20042225 Free PMC article.

3

Does one person provide it all? Primary support and advanced care planning for women with cancer.

Dizon DS, Gass JS, Bandera C, Weitzen S, Clark M. Dizon DS, et al. Among authors: bandera c. J Clin Oncol. 2007 Apr 10;25(11):1412-6. doi: 10.1200/JCO.2006.09.0845. J Clin Oncol. 2007. PMID: 17416861

4

Contemporary Approaches to High-risk, Early-Stage Serous Endometrial Cancer: Clinical Equipoise Persists.

Bandera C, Dizon DS. Bandera C, et al. Am J Clin Oncol. 2019 Feb;42(2):107-108. doi: 10.1097/COC.0000000000000475. Am J Clin Oncol. 2019. PMID: 29965808 No abstract available.

5

Fertility therapy in the setting of a history of invasive epithelial ovarian cancer.

Bandera CA, Cramer DW, Friedman AJ, Sheets EE. Bandera CA, et al. Gynecol Oncol. 1995 Jul;58(1):116-9. doi: 10.1006/gyno.1995.1193. Gynecol Oncol. 1995. PMID: 7789877 Review.

6

Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy.

Chu CS, Randall TC, Bandera CA, Rubin SC. Chu CS, et al. Among authors: bandera ca. Gynecol Oncol. 2003 Jan;88(1):62-5. doi: 10.1006/gyno.2002.6852. Gynecol Oncol. 2003. PMID: 12504629

7

New Approaches to Improving Survival After Neoadjuvant Chemotherapy: The Role of Intraperitoneal Therapy and Heated Intraperitoneal Chemotherapy in Ovarian Cancer.

Lopresti ML, Bandera CA, Miner TJ. Lopresti ML, et al. Among authors: bandera ca. Am Soc Clin Oncol Educ Book. 2019 Jan;39:19-23. doi: 10.1200/EDBK_100016. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099685 Free article. Review.

8

Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary.

Tsuda H, Bandera CA, Birrer MJ, Hashiguchi Y, Berkowitz RS, Mok SC. Tsuda H, et al. Among authors: bandera ca. Oncology. 2004;67(3-4):291-9. doi: 10.1159/000081330. Oncology. 2004. PMID: 15557791

9

Survival of BRCA1 negative ovarian cancer patients based on family history.

Chu CS, Morgan MA, Randall TC, Bandera CA, Rubin SC. Chu CS, et al. Among authors: bandera ca. Gynecol Oncol. 2001 Oct;83(1):109-14. doi: 10.1006/gyno.2001.6349. Gynecol Oncol. 2001. PMID: 11585421

10

Ovarian cancer is a heterogeneous disease.

Wang V, Li C, Lin M, Welch W, Bell D, Wong YF, Berkowitz R, Mok SC, Bandera CA. Wang V, et al. Among authors: bandera ca. Cancer Genet Cytogenet. 2005 Sep;161(2):170-3. doi: 10.1016/j.cancergencyto.2004.12.014. Cancer Genet Cytogenet. 2005. PMID: 16102589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters